Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs Morphine as Adjuvants in Supraclavicular Block
NCT07008443Phase 4Completed
- Start
- Jan 2024
- Primary completion
- Apr 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nalbuphine and morphine in postoperative pain (3 arms). Primary endpoint: Analgesic Duration up to 24 hours. Started Jan 2024; status: completed.
02
Drugs
nalbuphinemorphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07008443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07008443.